Under Analyst’s Radar: Pfizer Inc (NYSE:PFE)

Pfizer Inc (NYSE:PFE) share price plunged -0.38% or -0.13 points to reach at $34.25 during previous trading session. The stock’s price fluctuated within the range of $34.18 – $34.61 during previous trading session. A total of 31.39M shares exchanged hands, whereas the company’s average trading volume stands at 25.16M shares. Pfizer Inc (NYSE:PFE) has a market capitalization of $203.67B and most recently 5.96B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc (NYSE:PFE) is at 61.19.

According to sentiments of 19 analysts the mean estimates of short term price target for the company’s stock is marked at $38. The most optimistic analyst sees the stock reaching $52 while the most conventional predicts the target price at $33.

The consensus mean EPS for the current quarter is at $0.67 derived from a total of 12 estimates. According to analysts minimum EPS for the current quarter is expected at $0.62 and can go high up to $0.72. However a year ago during same quarter Pfizer Inc (NYSE:PFE) reported $0.67 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 12 analysts.

According to sentiments of 11 analysts the company is expected to report revenues of $13.13B for the current quarter. Bearish revenue estimates established at $12.86B while the bullish revenue forecast has been figured out at $13.38B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32 on the shares of Pfizer Inc (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc (NYSE:PFE)’s distance from 20 day simple moving average is 0.16% whereas its distance from 50 day simple moving average is 4% along with 3.42% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc (NYSE:PFE) shares were trading -5.76% below from the 52-week high mark of $36.35 and +20.88% above from the 52-week bottom of $28.33. The stock hit its 52-week high price on 8/1/16 and 52-week low price on 4/1/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 0.09% in the past one week and soared 1.87% during previous one month drive, the stock went up 5.36% during past quarter. In the last six months the stock’s performance soared 3.85% while yearly performance of the company advanced 18.22%.The company’s year to date (YTD) performance is at 6.52%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc (NYSE:PFE) has a Return on Assets (ROA) of 4.20%. The company currently has a Return on Equity (ROE) of 11.60% and a Return on Investment (ROI) of 7.80%. Average true range (ATR-14) of the company sets at 0.39, along with its weekly and monthly volatility of 1.06%, 1.09% respectively. Beta value of the stock stands at 0.97.

The company’s price to free cash flow for trailing twelve months is 30.97. Its quick ratio for most recent quarter is 1 along with current ratio for most recent quarter of 1.30. Total debt to equity ratio of the company for most recent quarter is 0.71 whereas long term debt to equity ratio for most recent quarter is 0.53.

Momentum Stock: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) share price plunged -0.32% or -0.11 points to reach at $34.32 during previous trading session. The stock’s price fluctuated within the range of $34.27 – $34.58 during previous trading session. A total of 43.39M shares exchanged hands, whereas the company’s average trading volume stands at 25.10M shares. Pfizer Inc. (NYSE:PFE) has a market capitalization of $202.55B and most recently 5.96B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc. (NYSE:PFE) is at 63.00.

According to sentiments of 19 analysts the mean estimates of short term price target for the company’s stock is marked at $38.000. The most optimistic analyst sees the stock reaching $52.00 while the most conventional predicts the target price at $33.00.

The consensus mean EPS for the current quarter is at $0.67 derived from a total of 12 estimates. According to analysts minimum EPS for the current quarter is expected at $0.62 and can go high up to $0.72. However a year ago during same quarter Pfizer Inc. (NYSE:PFE) reported $0.67 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 12 analysts.

According to sentiments of 11 analysts the company is expected to report revenues of $13.13B for the current quarter. Bearish revenue estimates established at $12.86B while the bullish revenue forecast has been figured out at $13.38B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.32on the shares of Pfizer Inc. (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 7 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc.(NYSE:PFE)’s distance from 20 day simple moving average is +0.58% whereas its distance from 50 day simple moving average is +4.37% along with +3.65% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc. (NYSE:PFE) shares were trading –5.57% below from the 52-week high mark of $36.35 and +23.95% above from the 52-week bottom of $27.69. The stock hit its 52-week high price on 08/01/16, and 52-week low price on 03/18/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 0.62% in the past one week and soared 2.42% during previous one month drive, the stock went up 5.64% during past quarter. In the last six months the stock’s performance soared 2.56% while yearly performance of the company advanced 21.41%.The company’s year to date (YTD) performance is at 6.74%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc. (NYSE:PFE) has a Return on Assets (ROA) of 4.20%. The company currently has a Return on Equity (ROE) of 11.60% and a Return on Investment (ROI) of 7.80%.Average true range (ATR-14) of the company sets at 0.40, along with its weekly and monthly volatility of 1.05%, 1.15% respectively. Beta value of the stock stands at 0.97.

The company’s price to free cash flow for trailing twelve months is 31.64. Its quick ratio for most recent quarter is 1.00 along with current ratio for most recent quarter of 1.30. Total debt to equity ratio of the company for most recent quarter is 0.71 whereas long term debt to equity ratio for most recent quarter is 0.53.

Analysts Reviews Summary: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) soared 0.03% during previous trade, a total of 18.84M shares exchanged hands compared with its average trading volume of 27.86M shares whereas its relative volume is 0.73. The stock has a market capitalization of $206B along with 5.95B outstanding shares. Stock’s intraday price range hit the peak level of $34.65 and touched the lowest level of $34.36.

Most recently Pfizer Inc. (NYSE:PFE)’s price target was revised on 02/02/17 and according to 20 analysts stock’s price will reach at $37.95 during 52 weeks with standard deviation of 5.05. Stock’s minimum price target estimates has been figured out at $33 while the maximum price target forecast is established at $52, if we look at the price target with an optimistic approach it has upside potential of 51% from its latest closing price of $34.52.

Historically, if we look at price target revisions, three week ago Pfizer Inc. (NYSE:PFE)’s price target was revised on 2/2/17 by the analysts, however the bullish price estimates of the stock set at $52 while the bearish estimates kept at $30 over the next one year. Stock’s 52-week target was retained at $37.85, the estimates indicates a standard deviation of 5.43.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 2.13. ABR value is precisely based on brokerage recommendations, where out of 16 brokerage recommendations 7 rate Pfizer Inc. (NYSE:PFE) stock a Strong Buy, 0 rate the stocks of the company a Buy, 9 rate Hold, 0 rate Sell and 0 recommend a Strong Sell. Most recently on 11/2/16 the stock of Pfizer Inc. (NYSE:PFE) downgraded by Argus from Buy to HoldNeutral. However previously on 10/13/16 it was downgraded by Jefferies from Buy to Hold. A research note issued on 11/25/15 the stock was upgraded by Sun Trust Rbsn Humphrey from Reduce to Neutral.

Pfizer Inc. (NYSE:PFE) performance over the past one year soared 19.87% whereas its year to date (YTD) performance indicated a bullish trend of 7.36%. During the last six months the stock climbed 1.21%. Quarterly performance of the company shows optimistic momentum of 8.50% while its last one month trend is positive with 9%. Stock’s weekly performance expressed up trend of 0.76%.

The company’s price sits 6.26% above from its 50-day moving average of $32.59 and 4.45% far from the stock’s 200-day moving average which is $32.90. Pfizer Inc. (NYSE:PFE)’s shares are currently trading -5.02% away from the 52-week high price of $36.35 and +24.67% far from the 52-week low price of $27.69.

According to consensus agreement of 12 analysts Pfizer Inc. (NYSE:PFE) will report earnings per share of $0.67 in their quarterly report and it is expected to announce the company’s results on 5/2/17. For the current quarter the company has high EPS estimates of $0.71 in contradiction of low EPS estimates of $0.62. However a year ago for the same quarter the company has reported $0.67 EPS. Current year EPS projections for Pfizer Inc. (NYSE:PFE) set at $2.56 according to the sentiments of 20 analysts, while its lowest earnings estimates are $2.45 and highest earnings estimates are $2.65.

According to 11 analysts, Pfizer Inc. (NYSE:PFE)’s revenue estimates for the current quarter are $13.15B meanwhile the company has high revenue estimates of $13.5B in contradiction of low revenue estimates of $12.86B. For the current year the company’s revenue estimates are $53.33B compared to low analyst estimates of $52.34B and high estimates of $53.99B according to the projection of 17 analysts.

Analysts’ Recommendations and Insider’s Trading Activity: Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (NYSE:PFE) exchanged hands 31,914,100 shares versus average trading capacity of 25.82M shares, while its relative trading volume is 1.24. Pfizer Inc. (NYSE:PFE)’s total market worth is $206.66B along with 5.95B outstanding shares.

Insiders has most recently took part in a trading activity, Lewis-Hall Freda C, Executive Vice President of the company in a transaction that occurred 2/27/2017 sold 8,515 shares of the stock. The stock was sold at a price of $34.28, for a total value of $291,894. Subsequent to the transaction Lewis-Hall Freda C owned a total of 221,623 shares of the stock.

In a separate transaction on 2/27/2017, Lewis-Hall Freda C, Executive Vice President sold 8,421 shares of the stock. The stock was sold at a price of $34.28, for a total worth of $288,672. Succeeding to the transaction Lewis-Hall Freda C owned overall 230,138 shares of the stock.

Moreover, Damelio Frank A, Executive Vice President sold 18,838 shares of the stock in a reserved transaction that ensued on 2/27/2017. At a price of $34.28, the stock was sold for an entire value of $645,767. Consequent to the transaction Damelio Frank A owned a total of 450,844 shares of the stock.

Currently, 0.04% shares of Pfizer Inc. (NYSE:PFE) are owned by insiders with -3.94% six-month change in the insider ownership. The insider filler data counts the number of monthly positions over 3 month and 12 month time spans. For Pfizer Inc. (NYSE:PFE) total 18 number of trades held during last 3 months and 37 during last 12 months, out of them 2 numbers of buys held in last 3 months and 2 buys in last 12 months. Whereas 16 numbers of sells held in last 3 months and 35 sells over the past 12 months.

For the duration of last three months Pfizer Inc. (NYSE:PFE)’s total number of shares bought are 35,301 and sold 1,295,746 from a total of 1,331,047 traded shares. During last twelve months 35,301 number of shares bought and 3,363,877 sold from a total of 3,399,178 shares traded. A net activity of 1,260,445 took place in the course of three months, while 3,328,576 during last twelve months. Insider trading information is derived from Forms 3 and 4 filings are filed with the U.S. Securities and Exchange Commission (SEC).

Pfizer Inc. (NYSE:PFE) ended last trading session at the price of $34.42 whereas a number of traders indicating mean target price will hit $37.95 over the next twelve months, mean value of price target most recently revised on 02/17/17. Pfizer Inc. (NYSE:PFE)’s highest estimates of price target are $52.00 and low forecast is $33.00 based on the opinion of 20 analysts. The price target estimates represents a standard deviation of 5.05. However brokerage recommendations suggests an ABR of 2.13 based on calls of 16 experts.

Pfizer Inc. (NYSE:PFE) is expected to release the earnings of its current quarter on 5/2/17. The company is expected to release $0.67 EPS during current quarter according to 12 analysts whereas the company reported $0.67 EPS during same quarter a year ago. For the current quarter the stock has a lowest EPS estimates of $0.62 and high estimate of $0.71. Pfizer Inc. (NYSE:PFE)’s average revenue estimates for the current quarter are $13.15B according to 11 number of analysts. However its lowest revenue estimates are $12.86B and highest revenue estimates are $13.5B. A year ago the company’s sales were $13.01B. Its yearly sales growth estimates are 1.10%. Past 5 years growth of Pfizer Inc. (NYSE:PFE) observed at 1.32%, and for the next five years the analysts that follow this company are expecting its growth at 6.24%.

Stock on Analyst Radar: Pfizer Inc (NYSE:PFE)

Pfizer Inc (NYSE:PFE) closed at $33.62 during previous trading session. The stock’s price fluctuated within the range of $33.53 – $33.89 during previous trading session. A total of 34.99M shares exchanged hands, whereas the company’s average trading volume stands at 27.02M shares. Pfizer Inc (NYSE:PFE) has a market capitalization of $204.69B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc (NYSE:PFE) is at 74.56.

According to sentiments of 21 analysts the mean estimates of short term price target for the company’s stock is marked at $37.48. The most optimistic analyst sees the stock reaching $52 while the most conventional predicts the target price at $30.

The consensus mean EPS for the current quarter is at $0.67 derived from a total of 12 estimates. According to analysts minimum EPS for the current quarter is expected at $0.62 and can go high up to $0.71. However a year ago during same quarter Pfizer Inc (NYSE:PFE) reported $0.67 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.67 per share according to consensus of 12 analysts.

According to sentiments of 11 analysts the company is expected to report revenues of $13.15B for the current quarter. Bearish revenue estimates established at $12.86B while the bullish revenue forecast has been figured out at $13.5B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.30 on the shares of Pfizer Inc (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 8 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc (NYSE:PFE)’s distance from 20 day simple moving average is 5.39% whereas its distance from 50 day simple moving average is 4.80% along with 1.96% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc (NYSE:PFE) shares were trading -7.50% below from the 52-week high mark of $36.35 and +21.42% above from the 52-week bottom of $27.69. The stock hit its 52-week high price on 8/1/16 and 52-week low price on 3/17/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 3.93% in the past one week and soared 7.14% during previous one month drive, the stock went up 6.27% during past quarter. In the last six months the stock’s performance plunged -2.53% while yearly performance of the company advanced 18.33%.The company’s year to date (YTD) performance is at 4.56%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc (NYSE:PFE) Average true range (ATR-14) of the company sets at 0.49, along with its weekly and monthly volatility of 1.58%, 1.41% respectively. Beta value of the stock stands at 0.96.

Noticeable Stock: Pfizer Inc (NYSE:PFE)

Pfizer Inc (NYSE:PFE) share price soared 1.13% or 0.36 points to reach at $32.09 during previous trading session. The stock’s price fluctuated within the range of $31.92 – $32.24 during previous trading session. A total of 35.99M shares exchanged hands, whereas the company’s average trading volume stands at 23.65M shares. Pfizer Inc (NYSE:PFE) has a market capitalization of $197.32B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc (NYSE:PFE) is at 57.69.

According to sentiments of 21 analysts the mean estimates of short term price target for the company’s stock is marked at $37.48. The most optimistic analyst sees the stock reaching $52 while the most conventional predicts the target price at $30.

The consensus mean EPS for the current quarter is at $0.66 derived from a total of 11 estimates. According to analysts minimum EPS for the current quarter is expected at $0.62 and can go high up to $0.71. However a year ago during same quarter Pfizer Inc (NYSE:PFE) reported $0.67 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.66 per share according to consensus of 11 analysts.

According to sentiments of 9 analysts the company is expected to report revenues of $13.14B for the current quarter. Bearish revenue estimates established at $12.86B while the bullish revenue forecast has been figured out at $13.5B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.30 on the shares of Pfizer Inc (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 8 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc (NYSE:PFE)’s distance from 20 day simple moving average is 0.80% whereas its distance from 50 day simple moving average is 0.83% along with -2.58% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc (NYSE:PFE) shares were trading -11.71% below from the 52-week high mark of $36.35 and +17.90% above from the 52-week bottom of $27.22. The stock hit its 52-week high price on 8/1/16 and 52-week low price on 2/8/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 3.17% in the past one week and plunged -2.62% during previous one month drive, the stock went up 6.89% during past quarter. In the last six months the stock’s performance plunged -6.86% while yearly performance of the company advanced 14.86%.The company’s year to date (YTD) performance is at -0.19%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.46, along with its weekly and monthly volatility of 1.67%, 1.49% respectively. Beta value of the stock stands at 0.92.

The company’s price to free cash flow for trailing twelve months is 109.34. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Steady Stock: Pfizer Inc (NYSE:PFE)

Pfizer Inc (NYSE:PFE) share price soared 0.83% or 0.26 points to reach at $31.67 during previous trading session. The stock’s price fluctuated within the range of $31.26 – $31.69 during previous trading session. A total of 28.46M shares exchanged hands, whereas the company’s average trading volume stands at 24M shares. Pfizer Inc (NYSE:PFE) has a market capitalization of $194.76B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc (NYSE:PFE) is at 50.93.

According to sentiments of 21 analysts the mean estimates of short term price target for the company’s stock is marked at $37.48. The most optimistic analyst sees the stock reaching $52 while the most conventional predicts the target price at $30.

The consensus mean EPS for the current quarter is at $0.66 derived from a total of 10 estimates. According to analysts minimum EPS for the current quarter is expected at $0.62 and can go high up to $0.71. However a year ago during same quarter Pfizer Inc (NYSE:PFE) reported $0.67 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.66 per share according to consensus of 10 analysts.

According to sentiments of 9 analysts the company is expected to report revenues of $13.15B for the current quarter. Bearish revenue estimates established at $12.86B while the bullish revenue forecast has been figured out at $13.5B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.30 on the shares of Pfizer Inc (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 8 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc (NYSE:PFE)’s distance from 20 day simple moving average is -1.87% whereas its distance from 50 day simple moving average is -1.45% along with -4.82% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc (NYSE:PFE) shares were trading -13.74% below from the 52-week high mark of $36.72 and +15.19% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 8/1/16 and 52-week low price on 2/8/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 2.25% in the past one week and plunged -1.50% during previous one month drive, the stock went up 1.90% during past quarter. In the last six months the stock’s performance plunged -10.47% while yearly performance of the company advanced 10.16%.The company’s year to date (YTD) performance is at -1.50%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.46, along with its weekly and monthly volatility of 1.56%, 1.48% respectively. Beta value of the stock stands at 0.92.

The company’s price to free cash flow for trailing twelve months is 107.91. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.

Stock Earnings in Review: Pfizer Inc. (NYSE:PFE)

Shares of Pfizer Inc. (NYSE:PFE) jumped 1.34% to reach at $31.73 during previous trading session. The company has experienced volume of 37,422,335 shares while on average the company has a capacity of trading 28.35M share.

Pfizer Inc. (NYSE:PFE) Pfizer Inc. (PFE) on January 31, 2017 reported financial results for fourth-quarter and full-year 2016.

Pfizer manages its commercial operations through two distinct businesses: Pfizer Innovative Health (IH) (formerly the Innovative Products business) and Pfizer Essential Health (EH) (formerly the Established Products business).

On September 3, 2015, Pfizer acquired Hospira, Inc. (Hospira). Consequently, financial results for the year ended December 31, 2016 reflect legacy Hospira global operations for the entire period while financial results for the year ended December 31, 2015 reflect only four months of legacy Hospira U.S. operations and three months of legacy Hospira international operations. Financial results for fourth-quarter 2016 and fourth-quarter 2015 include legacy Hospira global operations for both periods.

On June 24, 2016, Pfizer acquired Anacor Pharmaceuticals, Inc. (Anacor). Therefore, financial results for fourth-quarter and full-year 2016 reflect three months and approximately six months of legacy Anacor operations, respectively, which were immaterial.

On September 28, 2016, Pfizer acquired Medivation, Inc. (Medivation). Therefore, financial results for fourth-quarter and full-year 2016 reflect three months of legacy Medivation operations.

Pfizer Inc. (NYSE:PFE) holds the market capitalization of $195.13B along with 6.07B outstanding shares. During the last trade, stock’s minimum price has been reached out at $30.93 while the maximum trading price moved at $31.93. Currently the stock price is moving -13.58% off from the highest level of twelve months and +15.41% above from twelve months low. Pfizer Inc. (NYSE:PFE) marked 52-week highest price level of $36.72 on 08/01/16 and 52-week lowest price level of $27.49 on 02/08/16. For the stock, price target value has been calculated at $37.48 based on calls of 21 experts. Stock’s minimum price target estimates has been figured out at $30.00 while the maximum price target forecast is established at $52.00.

As of current trade, Pfizer Inc. (NYSE:PFE) has shown weekly upbeat performance of 1.86%. Its six months performance indicated a bearish movement while its yearly performance reflected a positive trend of 9.15%. Year-to-date (YTD) performance of the stock illustrate downbeat trend of -2.31%. Shares of Pfizer Inc. (NYSE:PFE) currently have an ABR of 2.06, derived from a total of 17 opinions. The company’s price sits -1.27% below from its 50-day moving average of $32.41 and -4.64% below from the stock’s 200-day moving average of $33.33. The company has Relative Strength Index (RSI 14) of 44.51 along with Average True Range (ATR 14) of 0.47. Its weekly and monthly volatility is 1.55%, 1.46% respectively. The company’s beta value is at 0.92.

Pfizer Inc. (NYSE:PFE) currently has a PEG ratio of 4.48 where as its P/E ratio is 31.67. The company’s price to sales ratio for trailing twelve months is 3.62 and price to book ratio for most recent quarter is 3.04, whereas price to cash per share for the most recent quarter is 13.40. Pfizer Inc. (NYSE:PFE)’s price to free cash flow for trailing twelve months is 108.11. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48. Pfizer Inc. (NYSE:PFE) has a Return on Assets of 3.60%. The company currently has a Return on Equity of 9.70% and Return on Investment of 7.30%.

Pfizer Inc. (NYSE:PFE): Can the Stock Surprise in Next Earnings?

Pfizer Inc. (NYSE:PFE) plunged -0.38% or -0.12 points during previous trade after opening at the price of $31.47, a total of 27,424,200 shares exchanged hands compared with its average trading volume of 28.33M shares. The stock has a market capitalization of $190.85B and it has 6.07B outstanding shares.

According to consensus agreement of 18 analysts Pfizer Inc. (NYSE:PFE) will report earnings per share of $0.5 in their quarterly report and it is expected to announce the company’s results on 1/31/17 Before Market Open. The stock added almost 0.1% in price since last earning report, when its share price was $31.40. For the current quarter the company has highest EPS estimates of $0.54 and low forecast is $0.47. However a year ago for the same quarter the company has reported $0.53 earnings per share.

Earnings reaction history indicates that share price went down 15 times out of last 28 quarters. In Pfizer Inc. (NYSE:PFE)’s last 12 earnings reports, it has beaten EPS estimates 91% of the time. However it has meet the estimates 0 time and missed 1 time.

If we have a peek on EPS and surprise factor history during last four quarters, for the previous quarter ended on 9/2016, the consensus mean EPS was $0.62 while Pfizer Inc. (NYSE:PFE) reported $0.61 EPS on 11/1/2016 Before Market Open with a difference of -0.01 marking a surprise factor of -1.61%. The stock’s next day closing price was $30.76 with the loss of -2.04% in its share price. On seventh day of the earnings report price change of the stock was -4.20%.

Previously for the quarter ended on 6/2016, Pfizer Inc. (NYSE:PFE)’s expected mean EPS was $0.62, the company reported its quarterly earnings per share of $0.64 on 8/2/2016 Before Market Open, beating the analysts’ consensus estimate by 0.02 with surprise factor of 3.23%. The stock’s closing price was $35.73 with the loss of -2.46% in its share price on the day following the earning announcement. However price change of the stock was -5.60% on seventh day of the earnings report.

Pfizer Inc. (NYSE:PFE)’s mean EPS estimate was $0.55 for the quarter ended on 3/2016, while it reported EPS of $0.67 on 5/3/2016 Before Market Open, beating the analysts’ consensus estimate by 0.12 with surprise factor of 21.82%. On next day when data was publically announced, the stock’s closing price was $32.79 with 2.76% gain in its share price. On seventh day of the earnings report price change of the stock was up 3.13%.

Back on 2/2/2016 the company’s estimated EPS value was $0.52 and it reported $0.53 earnings per share (EPS) for the quarter ended on 12/2015. The company posted a positive surprise factor of 1.92% by 0.01.

Average EPS forecast for the current year is $2.41 according to 20 analysts making projections for Pfizer Inc. (NYSE:PFE). The most expectant earnings per share estimate of the stock is set at $2.45 while the conservative estimates kept at $2.38 over the current year. Having a look at the historical EPS report, the company attained $2.2 EPS for the previous year. While revenue estimates for the current year is $52.86B, Pfizer Inc. (NYSE:PFE) setting the highest revenues estimates of $53.57B and indicating lowest revenues at $52.11B according to agreement of 17 number of analysts. Current quarter revenue movements show that, the company has set average revenue estimates of $13.63B covering forecast of 16 analysts. The company indicates a peak revenue level of $14.37B and $12.91B at bottom level.

Having a glance at growth estimates of the company, it has current quarter growth estimates of -5.70% whereas for next quarter it has -1.50% estimations over growth. Its forecasts over growth are 9.50% during current year while analysts’ growth estimation for the next year is 6.60%. Past 5 years growth of Pfizer Inc. (NYSE:PFE) observed at 1.78%, and for the next five years the analysts that follow this company are expecting its growth at 7.12%.

Pfizer Inc. (NYSE:PFE) reached at $31.31 price level during last trade its distance from 20 days simple moving average is -3.27%, and its distance from 50 days simple moving average is -2.64% while it has a distance of -5.91% from the 200 days simple moving average. One year trading price range hit the peak level of $36.72 and touched the lowest level of $27.49. The company’s distance from 52-week high price is -14.72% and current price is above +13.88% from 52-week low price.

Noticeable Stock: Notable Mover: Pfizer Inc (NYSE:PFE)

Pfizer Inc (NYSE:PFE) share price plunged -0.99% or -0.31 points to reach at $31.15 during previous trading session. The stock’s price fluctuated within the range of $30.90 – $31.46 during previous trading session. A total of 29.63M shares exchanged hands, whereas the company’s average trading volume stands at 24.17M shares. Pfizer Inc (NYSE:PFE) has a market capitalization of $187.18B and most recently 6.07B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Pfizer Inc (NYSE:PFE) is at 31.47.

According to sentiments of 21 analysts the mean estimates of short term price target for the company’s stock is marked at $37.52. The most optimistic analyst sees the stock reaching $53 while the most conventional predicts the target price at $30.

The consensus mean EPS for the current quarter is at $0.5 derived from a total of 18 estimates. According to analysts minimum EPS for the current quarter is expected at $0.47 and can go high up to $0.54. However a year ago during same quarter Pfizer Inc (NYSE:PFE) reported $0.53 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $0.68 per share according to consensus of 5 analysts.

According to sentiments of 16 analysts the company is expected to report revenues of $13.63B for the current quarter. Bearish revenue estimates established at $12.91B while the bullish revenue forecast has been figured out at $14.37B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.30 on the shares of Pfizer Inc (NYSE:PFE). Out of rating recommendations 4 have given the stock a Buy while 8 recommend the stock as Outperform. 11 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Pfizer Inc (NYSE:PFE)’s distance from 20 day simple moving average is -4.44% whereas its distance from 50 day simple moving average is -3.46% along with -6.39% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Pfizer Inc (NYSE:PFE) shares were trading -15.16% below from the 52-week high mark of $36.72 and +13.30% above from the 52-week bottom of $27.49. The stock hit its 52-week high price on 8/1/16 and 52-week low price on 2/8/16.

When we have a peek on stock’s historical trends we come to know that, the stock has slipped -2.84% in the past one week and plunged -3.86% during previous one month drive, the stock went down -2.24% during past quarter. In the last six months the stock’s performance plunged -13.75% while yearly performance of the company advanced 5.99%.The company’s year to date (YTD) performance is at -4.09%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc (NYSE:PFE) has a Return on Assets (ROA) of 3.60%. The company currently has a Return on Equity (ROE) of 9.70% and a Return on Investment (ROI) of 7.30%. Average true range (ATR-14) of the company sets at 0.46, along with its weekly and monthly volatility of 1.46%, 1.30% respectively. Beta value of the stock stands at 0.94.

The company’s price to free cash flow for trailing twelve months is 106.10. Its quick ratio for most recent quarter is 0.90 along with current ratio for most recent quarter of 1.10. Total debt to equity ratio of the company for most recent quarter is 0.70 whereas long term debt to equity ratio for most recent quarter is 0.48.